AAO-HNSF Clinical Practice Guideline Update

Public Comment – Clinical Practice Guideline: Otitis Media with Effusion (OME) Update

Monday, August 10 - Monday, August 24 

A draft of the update AAO-HNSF Clinical Practice Guideline: Otitis Media with Effusion (OME) is now available for public comment. The comment period will run from Monday, August 10 through Monday, August 24. During this time, members of the public are encouraged to review the guideline and provide comments. While the goal of this phase is to obtain public comment, we also encourge other stakeholders to participate, if they so desire. The purpose of the comment period is to ensure that all stakeholders have an opportunity to review the guideline recommendations, action statement profiles, and supporting text prior to publication.

Please remember that this guideline update is intended for all clinicians who are likely to diagnose and manage children with OME and applies to any setting in which a child with OME would be identified, monitored, or managed. The target population is children aged 2 months through 12 years.

We ask that non-healthcare professionals, specifically, pay close attention to the evidence profile of each action statement. Action statement profiles contain information regarding the role of patient preferences, benefit/harm assessment, and intentional vagueness, which may be most relevant to members of the public.

To participate in the public comment, users must agree not to distribute or share the draft guideline with any other individuals or organizations prior to the official publication of the guideline, and must disclose any conflicts of interest. Following conflict of interest disclosure, a PDF of the guideline document will then become available, and users will receive a link to the comment page.

The guideline development panel will review all submitted comments. Please note that the guideline panel will not be providing responses to comments received. If necessary, individuals may be contacted for comment clarification.